NEXT Oncology, 2829 Babcock Road Suite 300 — San Antonio, Texas

NEXT Oncology, 2829 Babcock Road Suite 300 is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NEXT Oncology, 2829 Babcock Road Suite 300 has participated in 1 clinical trials.

Therapeutic areas: Resistant or Refractory Solid Tumors.

Sponsors: Calgent Biotechnology Co., Ltd.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology, 2829 Babcock Road Suite 300?

NEXT Oncology, 2829 Babcock Road Suite 300 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology, 2829 Babcock Road Suite 300 conducted?

NEXT Oncology, 2829 Babcock Road Suite 300 has 1 clinical trials on record. Their work covers Resistant or Refractory Solid Tumors.

Is NEXT Oncology, 2829 Babcock Road Suite 300 accredited by Crixeo Health?

NEXT Oncology, 2829 Babcock Road Suite 300 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Oncology, 2829 Babcock Road Suite 300?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.